General practitioners’ perspectives on statutory skin cancer screening–A questionnaire-based cross-sectional survey in Germany
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308508 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Lydia Reinhardt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: General Practitioners, Early Detection of Cancer, Skin Neoplasms. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftung Hochschulmedizin Dresden.
Abstract (Originalsprache)
Background
In Germany, skin cancer screening (SCS) is available free of charge every two years to all those with statutory health insurance over the age of 35. General Practitioners (GP) can carry out the screening if they have completed an 8-hour training course. GPs play a crucial role in the implementation of SCS and act as gatekeepers between initial patient contact and referral to dermatologists.
Objective
To record how comprehensively GPs carry out SCS in terms of patient information and body examination, as well as to explore GPs opinions on the feasibility of SCS.
Methods
A cross-sectional survey was conducted. A questionnaire was sent to GPs with permission to perform SCS in two regions of Germany (Bavaria and Saxony) between August and September 2021. Data were analyzed using descriptive analysis. Subgroup analysis was performed according to regions (federal state, location of physician´s office), professional experience (experience in years, number of monthly screenings, age) and gender. Open questions were evaluated using qualitative content analysis.
Results
In the survey, 204 GPs responded. Genitalia (40.7%, 83/203), anal fold (62.3%, 127/204) and oral mucosa (66.7%, 136/204) were the least examined body regions during screening. Information on risks (false-positive findings: 18.6%, 38/203; false-negative findings: 13.2%, 27/203; overdiagnosis: 7.8%, 16/203) and benefits (48.0%, 98/202) were not always provided. GPs who performed screenings more frequently were more likely to provide information about the benefits of SCS (p10 vs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
- Skin Cancer Center at the National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
- Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), Erlangen, Germany.
ORCID-Profile: Lydia Reinhardt, Anja Wessely
Förderung
- Stiftung Hochschulmedizin Dresden
Zitieren
APA
Reinhardt, L., Strasser, C., Steeb, T., Petzold, A., Heppt, M. V., Wessely, A., Berking, C., & Meier, F. (2024). General practitioners’ perspectives on statutory skin cancer screening–A questionnaire-based cross-sectional survey in Germany. PLOS ONE. https://doi.org/10.1371/journal.pone.0308508
Vancouver
Reinhardt L, Strasser C, Steeb T, Petzold A, Heppt MV, Wessely A, et al. General practitioners’ perspectives on statutory skin cancer screening–A questionnaire-based cross-sectional survey in Germany. PLOS ONE. 2024. doi:10.1371/journal.pone.0308508
BibTeX
@article{Reinhardt2024,
author = {Reinhardt, Lydia and Strasser, Cristin and Steeb, Theresa and Petzold, Anne and Heppt, Markus V and Wessely, Anja and Berking, Carola and Meier, Friedegund},
title = {General practitioners’ perspectives on statutory skin cancer screening–A questionnaire-based cross-sectional survey in Germany},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308508}
}
EUVIMED